Skip to content

Efficacy of Laser Acupuncture on Neurophysiological Parameters of Median Nerve in Postpartum Women

Efficacy of Laser Acupuncture on Neurophysiological Parameters of Median Nerve in Postpartum Women: A Randomized Controlled Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05846958
Acronym
CTSLA
Enrollment
50
Registered
2023-05-06
Start date
2023-04-01
Completion date
2023-07-28
Last updated
2023-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurophysiologic Abnormality

Brief summary

BACKGROUND: Carpal tunnel syndrome (CTS), the most common entrapment neuropathy of the upper extremity, is caused by compression of the median nerve as it travels through the carpal tunnel CTs is a very common complication found in pregnancy, which is reported as high as 62% in pregnant females. The functioning of median nerve is compromised in almost all pregnant females especially during the third trimester of pregnancy, the majority may still feel some symptoms up to 3 years after delivery. Many clinicians have used LLLT on acupuncture points, which is called laser acupuncture (LA), to treat many clinical problems, such as musculoskeletal pain, lateral epicondylitis, headaches, etc. In contrast with traditional acupuncture needles, LA is a non-invasive therapy that does not cause tingling/pain during procedures Objective: to determine efficacy of laser acupuncture on electrophysiological parameters of median nerve in postpartum women

Detailed description

Intervention description 1. Experimental Group: Each patient in this group will receive laser acupuncture on PC4 (Ximen), PC6 (Neiguan), PC7 (Daling), PC8 (Laogong), LI4 (Hegu), LI10 (Shousanli), LI11 (Quchi), HT3 (Shaohai), HT7 (Shenmen), LU10 (Yuji) acupoints in addition to wearing night splint. LA will be applied to each acupuncture point for 10 s with at least 4J/points based on the recommended LLLT treatment doses for CTS of the World Association of Laser Therapy. 2. Control Group: Each patient in this group will wear night splint every night for 4 weeks

Interventions

DEVICElaser acupuncture

Each patient in experimental group will receive laser acupuncture for 10 s with at least 4J/point for each point.10 minutes, three times per week for 4 weeks (total of 12 sessions) nieght splint for 4 weeks .

wearing night splint for 4 weeks

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Their BMI will be range from 25 to 30 Kg/m2. * The electrophysiological evidence of mild or moderate median nerve lesion at wrist (mild: sensory nerve latency \>3.5 ms at third digit, moderate: sensory nerve latency \>3.5 ms at third digit and median motor latency\>4.2 ms) * Positive phalen's test. * Positive tinel's test. * Carpal tunnel of dominant hand could be participated.

Exclusion criteria

* History of brachial plexopathy or malignancy. * Radial, ulnar neuropathy, proximal median neuropathy or polyneuropathy. * Previous wrist surgery or steroid injection for carpal tunnel syndrome. * History of trauma, fracture, deformity or inflammation in the wrist, such as rheumatoid arthritis. * Coagulation abnormalities, pregnancy, fever and infections. * Skin disease and skin cancer. * Spots, birthmarks or tattoos over the work points. 8- Pacemaker and implementable medical devices.

Design outcomes

Primary

MeasureTime frameDescription
sensory nerve conduction velocity (SNCV) measured in m/s4 weekswill be measured at the beginning of the study and at the end of the treatment program througth EMG

Secondary

MeasureTime frameDescription
Hand grip strength in Kg4 weekswill be measured at the beginning of the study and at the end of the treatment program using pinch grip dynamometer
Symptoms severity and functional capacity (Score)4 weekswill be measured at the beginning of the study and at the end of the treatment program using Boston symptoms severity scale (BSSS)

Countries

Egypt

Contacts

Primary ContactAfaf M Botla, professor
drafafmohamed@yahoo.com002701283126608
Backup ContactManal A ElShafei, Lecturer
manal.ahmed@cu.edu.eg002701220664518

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026